Press Releases on May 13, 2020 - EIN Presswire - Press Release Distribution Service

Published on May 13, 2020 - 21:12 GMT

Kiniksa Pharmaceuticals, Ltd. Announces Proposed Public Offering

HAMILTON, Bermuda, May 13, 2020 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa,” “we,” and “our”) announced today that it is commencing a public offering of 1,800,000 of its Class A common shares. In addition, Kiniksa expects to …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on May 13, 2020 - 21:12 GMT

Align Technology Announces That Its 2020 Annual Meeting Of Stockholders Will Be Held At 1 P.M. Pacific Daylight Time On May 20, ...

SAN JOSE, Calif., May 13, 2020 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) today announced that due to circumstances related to the COVID-19 pandemic and to prioritize the health and well-being of our stockholders, employees, officers, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on May 13, 2020 - 21:11 GMT

Acreage Provides Update on Timing of Filing of Financial Statements for 2019

NEW YORK, May 13, 2020 (GLOBE NEWSWIRE) -- Acreage Holdings, Inc. (“Acreage” or the “Company”) (CSE: ACRG.U) (OTCQX: ACRGF) (FSE: 0VZ) announced that it will file a Form 12b-25 with the U.S. Securities and Exchange Commission relating to the Company’s …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on May 13, 2020 - 21:10 GMT

MacroGenics Announces Preliminary Clinical Results from MGD013 and MGC018 to be Presented at the ASCO Annual Meeting

Rockville, MD, May 13, 2020 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 13, 2020 - 21:08 GMT

Osmotica Pharmaceuticals plc to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference

BRIDGEWATER, N.J., May 13, 2020 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that Brian Markison, Chief Executive Officer, and Andrew Einhorn, …

Distribution channels:

Published on May 13, 2020 - 21:05 GMT

Western Provides Update for Annual General Meeting

VANCOUVER, British Columbia, May 13, 2020 (GLOBE NEWSWIRE) -- Western Forest Products Inc. (TSX: WEF) (“Western” or the “Company”) announced today additional precautionary measures for its upcoming annual general meeting (“AGM”) which will be held at 9:00 …

Distribution channels: Agriculture, Farming & Forestry Industry, Culture, Society & Lifestyle ...

Published on May 13, 2020 - 21:05 GMT

PDS Biotechnology Announces Publication at American Society of Clinical Oncology (ASCO) 2020

FLORHAM PARK, N.J., May 13, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on May 13, 2020 - 21:04 GMT

CFOs2GO and the 2GO Group Expands its Revenue Consulting Services Offering

New Partner, Brian Dunkel Joins as Co-Managing Partner of CROs2GO WALNUT CREEK, CA, UNITED STATES, May 13, 2020 /⁨EINPresswire.com⁩/ -- CFOs2GO, a leading provider of C-level executive expertise on a part-time, interim and advisory basis as well as …

Distribution channels: Banking, Finance & Investment Industry, Consumer Goods ...

Published on May 13, 2020 - 21:02 GMT

Vaccinex to Present Updated Results from CLASSICAL-Lung, Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (...

ROCHESTER, N.Y., May 13, 2020 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today announced …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on May 13, 2020 - 21:02 GMT

IPL Plastics Inc. Announced Executive Management Changes

MONTREAL, May 13, 2020 (GLOBE NEWSWIRE) -- IPL Plastics Inc. (“IPLP” or the “Company”) (TSX: IPLP) today announced that Chief Financial Officer, Pat Dalton, is leaving the Company and resigning from the Board of Directors, effective immediately to pursue …

Distribution channels: Companies, Consumer Goods ...

Published on May 13, 2020 - 21:01 GMT

Iovance Biotherapeutics Announces Clinical Data Updates for Lifileucel in Advanced Melanoma

Median Duration of Response Not Reached at 17.0 Months of Median Study Follow Up in C-144-01 Study Oral Presentation to Include Additional Cohort 2 Data from C-144-01 Clinical Study at ASCO 2020 Virtual Scientific Program SAN CARLOS, Calif., May 13, 2020 …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on May 13, 2020 - 21:01 GMT

Arcellx to Present Preclinical Data of its Novel ARC-sparX Platform Technology in Targeting HER2+ Solid Tumors at the 2020 ...

GAITHERSBURG, Md., May 13, 2020 (GLOBE NEWSWIRE) -- Arcellx, a clinical-stage biopharmaceutical company developing novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases, today announced that it …

Distribution channels: Culture, Society & Lifestyle ...

Published on May 13, 2020 - 21:01 GMT

Agios to Present Updated Data from the Phase 1 Study of Vorasidenib in Non-enhancing Glioma in Oral Presentation at the American ...

CAMBRIDGE, Mass., May 13, 2020 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that vorasidenib and ivosidenib clinical data will be …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 13, 2020 - 21:01 GMT

Immunomedics to Present New Trodelvy™ Data In Non-Breast Cancer Indications at the 2020 ASCO Virtual Meeting

MORRIS PLAINS, N.J., May 13, 2020 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced that its recently FDA-approved …

Distribution channels: Culture, Society & Lifestyle, Media, Advertising & PR ...